PubMed:10362840
Annnotations
CL-cell
| Id | Subject | Object | Predicate | Lexical cue | cl_id |
|---|---|---|---|---|---|
| T1 | 231-257 | Cell | denotes | vascular endothelial cells | http://purl.obolibrary.org/obo/CL:0002139 |
| T2 | 1123-1145 | Cell | denotes | vein endothelial cells | http://purl.obolibrary.org/obo/CL:0002543 |
Glycan-Motif
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T1 | 23-30 | https://glytoucan.org/Structures/Glycans/G00021MO | denotes | heparin |
| T2 | 23-30 | https://glytoucan.org/Structures/Glycans/G54161DR | denotes | heparin |
| T3 | 173-180 | https://glytoucan.org/Structures/Glycans/G00021MO | denotes | heparin |
| T4 | 173-180 | https://glytoucan.org/Structures/Glycans/G54161DR | denotes | heparin |
| T5 | 293-300 | https://glytoucan.org/Structures/Glycans/G00021MO | denotes | heparin |
| T6 | 293-300 | https://glytoucan.org/Structures/Glycans/G54161DR | denotes | heparin |
| T7 | 437-444 | https://glytoucan.org/Structures/Glycans/G00021MO | denotes | heparin |
| T8 | 437-444 | https://glytoucan.org/Structures/Glycans/G54161DR | denotes | heparin |
| T9 | 474-481 | https://glytoucan.org/Structures/Glycans/G00021MO | denotes | heparin |
| T10 | 474-481 | https://glytoucan.org/Structures/Glycans/G54161DR | denotes | heparin |
| T11 | 556-563 | https://glytoucan.org/Structures/Glycans/G00021MO | denotes | heparin |
| T12 | 556-563 | https://glytoucan.org/Structures/Glycans/G54161DR | denotes | heparin |
| T13 | 594-601 | https://glytoucan.org/Structures/Glycans/G00021MO | denotes | heparin |
| T14 | 594-601 | https://glytoucan.org/Structures/Glycans/G54161DR | denotes | heparin |
| T15 | 640-647 | https://glytoucan.org/Structures/Glycans/G00021MO | denotes | heparin |
| T16 | 640-647 | https://glytoucan.org/Structures/Glycans/G54161DR | denotes | heparin |
| T17 | 727-734 | https://glytoucan.org/Structures/Glycans/G00021MO | denotes | heparin |
| T18 | 727-734 | https://glytoucan.org/Structures/Glycans/G54161DR | denotes | heparin |
| T19 | 829-836 | https://glytoucan.org/Structures/Glycans/G00021MO | denotes | heparin |
| T20 | 829-836 | https://glytoucan.org/Structures/Glycans/G54161DR | denotes | heparin |
| T21 | 1012-1019 | https://glytoucan.org/Structures/Glycans/G00021MO | denotes | heparin |
| T22 | 1012-1019 | https://glytoucan.org/Structures/Glycans/G54161DR | denotes | heparin |
| T23 | 1031-1038 | https://glytoucan.org/Structures/Glycans/G00021MO | denotes | heparin |
| T24 | 1031-1038 | https://glytoucan.org/Structures/Glycans/G54161DR | denotes | heparin |
| T25 | 1230-1237 | https://glytoucan.org/Structures/Glycans/G00021MO | denotes | heparin |
| T26 | 1230-1237 | https://glytoucan.org/Structures/Glycans/G54161DR | denotes | heparin |
GlyCosmos6-Glycan-Motif-Image
| Id | Subject | Object | Predicate | Lexical cue | image |
|---|---|---|---|---|---|
| T1 | 23-30 | Glycan_Motif | denotes | heparin | https://api.glycosmos.org/wurcs2image/0.10.0/png/binary/G54161DR|https://api.glycosmos.org/wurcs2image/0.10.0/png/binary/G00021MO |
| T3 | 173-180 | Glycan_Motif | denotes | heparin | https://api.glycosmos.org/wurcs2image/0.10.0/png/binary/G54161DR|https://api.glycosmos.org/wurcs2image/0.10.0/png/binary/G00021MO |
| T5 | 293-300 | Glycan_Motif | denotes | heparin | https://api.glycosmos.org/wurcs2image/0.10.0/png/binary/G54161DR|https://api.glycosmos.org/wurcs2image/0.10.0/png/binary/G00021MO |
| T7 | 437-444 | Glycan_Motif | denotes | heparin | https://api.glycosmos.org/wurcs2image/0.10.0/png/binary/G54161DR|https://api.glycosmos.org/wurcs2image/0.10.0/png/binary/G00021MO |
| T9 | 474-481 | Glycan_Motif | denotes | heparin | https://api.glycosmos.org/wurcs2image/0.10.0/png/binary/G54161DR|https://api.glycosmos.org/wurcs2image/0.10.0/png/binary/G00021MO |
| T11 | 556-563 | Glycan_Motif | denotes | heparin | https://api.glycosmos.org/wurcs2image/0.10.0/png/binary/G54161DR|https://api.glycosmos.org/wurcs2image/0.10.0/png/binary/G00021MO |
| T13 | 594-601 | Glycan_Motif | denotes | heparin | https://api.glycosmos.org/wurcs2image/0.10.0/png/binary/G54161DR|https://api.glycosmos.org/wurcs2image/0.10.0/png/binary/G00021MO |
| T15 | 640-647 | Glycan_Motif | denotes | heparin | https://api.glycosmos.org/wurcs2image/0.10.0/png/binary/G54161DR|https://api.glycosmos.org/wurcs2image/0.10.0/png/binary/G00021MO |
| T17 | 727-734 | Glycan_Motif | denotes | heparin | https://api.glycosmos.org/wurcs2image/0.10.0/png/binary/G54161DR|https://api.glycosmos.org/wurcs2image/0.10.0/png/binary/G00021MO |
| T19 | 829-836 | Glycan_Motif | denotes | heparin | https://api.glycosmos.org/wurcs2image/0.10.0/png/binary/G54161DR|https://api.glycosmos.org/wurcs2image/0.10.0/png/binary/G00021MO |
| T21 | 1012-1019 | Glycan_Motif | denotes | heparin | https://api.glycosmos.org/wurcs2image/0.10.0/png/binary/G54161DR|https://api.glycosmos.org/wurcs2image/0.10.0/png/binary/G00021MO |
| T23 | 1031-1038 | Glycan_Motif | denotes | heparin | https://api.glycosmos.org/wurcs2image/0.10.0/png/binary/G54161DR|https://api.glycosmos.org/wurcs2image/0.10.0/png/binary/G00021MO |
| T25 | 1230-1237 | Glycan_Motif | denotes | heparin | https://api.glycosmos.org/wurcs2image/0.10.0/png/binary/G54161DR|https://api.glycosmos.org/wurcs2image/0.10.0/png/binary/G00021MO |
sentences
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| TextSentencer_T1 | 0-95 | Sentence | denotes | Structural features in heparin that interact with VEGF165 and modulate its biological activity. |
| TextSentencer_T2 | 96-258 | Sentence | denotes | The 165 amino acid form of vascular endothelial growth factor (VEGF165) is a heparin-binding growth factor with mitogenic activity for vascular endothelial cells. |
| TextSentencer_T3 | 259-466 | Sentence | denotes | We examined activities of various heparin derivatives toward their interactions with VEGF165 using an enzyme-linked immunosorbent assay and elucidated the structural features in heparin for the interactions. |
| TextSentencer_T4 | 467-610 | Sentence | denotes | Native heparin interacted with VEGF165, whereas N-desulfated, N-acetylated (N-DS, N-Ac-) heparin, and 6-O-desulfated (6-O-DS-) heparin did not. |
| TextSentencer_T5 | 611-702 | Sentence | denotes | The 2-O-desulfated (2-O-DS-) heparin retained the ability for the interaction with VEGF165. |
| TextSentencer_T6 | 703-795 | Sentence | denotes | In contrast, the 2-O-DS-heparin exhibited no ability for the interaction with FGF-2 and HGF. |
| TextSentencer_T7 | 796-973 | Sentence | denotes | Thus, structural requirements in heparin for the specific interaction with VEGF165 are distinct from those with FGF-2 and HGF which require a high content of 2-O-sulfate groups. |
| TextSentencer_T8 | 974-1300 | Sentence | denotes | In a cell proliferation assay, native heparin and 2-O-DS-heparin exhibited inhibitory abilities for VEGF165-induced proliferation of human umbilical vein endothelial cells (HUVECs) with their high concentrations (more than 64 microg/ml), while only native heparin could enhance the proliferation of the chlorate-treated cells. |
| TextSentencer_T9 | 1301-1504 | Sentence | denotes | These results suggested that a high content of 2-O-sulfate groups is not required for the specific interaction with VEGF165alone, although it is essential for the mitogenic activity of the growth factor. |
| T1 | 0-95 | Sentence | denotes | Structural features in heparin that interact with VEGF165 and modulate its biological activity. |
| T2 | 96-258 | Sentence | denotes | The 165 amino acid form of vascular endothelial growth factor (VEGF165) is a heparin-binding growth factor with mitogenic activity for vascular endothelial cells. |
| T3 | 259-466 | Sentence | denotes | We examined activities of various heparin derivatives toward their interactions with VEGF165 using an enzyme-linked immunosorbent assay and elucidated the structural features in heparin for the interactions. |
| T4 | 467-610 | Sentence | denotes | Native heparin interacted with VEGF165, whereas N-desulfated, N-acetylated (N-DS, N-Ac-) heparin, and 6-O-desulfated (6-O-DS-) heparin did not. |
| T5 | 611-702 | Sentence | denotes | The 2-O-desulfated (2-O-DS-) heparin retained the ability for the interaction with VEGF165. |
| T6 | 703-795 | Sentence | denotes | In contrast, the 2-O-DS-heparin exhibited no ability for the interaction with FGF-2 and HGF. |
| T7 | 796-973 | Sentence | denotes | Thus, structural requirements in heparin for the specific interaction with VEGF165 are distinct from those with FGF-2 and HGF which require a high content of 2-O-sulfate groups. |
| T8 | 974-1300 | Sentence | denotes | In a cell proliferation assay, native heparin and 2-O-DS-heparin exhibited inhibitory abilities for VEGF165-induced proliferation of human umbilical vein endothelial cells (HUVECs) with their high concentrations (more than 64 microg/ml), while only native heparin could enhance the proliferation of the chlorate-treated cells. |
| T9 | 1301-1504 | Sentence | denotes | These results suggested that a high content of 2-O-sulfate groups is not required for the specific interaction with VEGF165alone, although it is essential for the mitogenic activity of the growth factor. |
| T1 | 0-95 | Sentence | denotes | Structural features in heparin that interact with VEGF165 and modulate its biological activity. |
| T2 | 96-258 | Sentence | denotes | The 165 amino acid form of vascular endothelial growth factor (VEGF165) is a heparin-binding growth factor with mitogenic activity for vascular endothelial cells. |
| T3 | 259-466 | Sentence | denotes | We examined activities of various heparin derivatives toward their interactions with VEGF165 using an enzyme-linked immunosorbent assay and elucidated the structural features in heparin for the interactions. |
| T4 | 467-610 | Sentence | denotes | Native heparin interacted with VEGF165, whereas N-desulfated, N-acetylated (N-DS, N-Ac-) heparin, and 6-O-desulfated (6-O-DS-) heparin did not. |
| T5 | 611-702 | Sentence | denotes | The 2-O-desulfated (2-O-DS-) heparin retained the ability for the interaction with VEGF165. |
| T6 | 703-795 | Sentence | denotes | In contrast, the 2-O-DS-heparin exhibited no ability for the interaction with FGF-2 and HGF. |
| T7 | 796-973 | Sentence | denotes | Thus, structural requirements in heparin for the specific interaction with VEGF165 are distinct from those with FGF-2 and HGF which require a high content of 2-O-sulfate groups. |
| T8 | 974-1300 | Sentence | denotes | In a cell proliferation assay, native heparin and 2-O-DS-heparin exhibited inhibitory abilities for VEGF165-induced proliferation of human umbilical vein endothelial cells (HUVECs) with their high concentrations (more than 64 microg/ml), while only native heparin could enhance the proliferation of the chlorate-treated cells. |
| T9 | 1301-1504 | Sentence | denotes | These results suggested that a high content of 2-O-sulfate groups is not required for the specific interaction with VEGF165alone, although it is essential for the mitogenic activity of the growth factor. |
GlyCosmos6-Glycan-Motif-Structure
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T1 | 23-30 | https://glytoucan.org/Structures/Glycans/G00021MO | denotes | heparin |
| T2 | 23-30 | https://glytoucan.org/Structures/Glycans/G54161DR | denotes | heparin |
| T3 | 173-180 | https://glytoucan.org/Structures/Glycans/G00021MO | denotes | heparin |
| T4 | 173-180 | https://glytoucan.org/Structures/Glycans/G54161DR | denotes | heparin |
| T5 | 293-300 | https://glytoucan.org/Structures/Glycans/G00021MO | denotes | heparin |
| T6 | 293-300 | https://glytoucan.org/Structures/Glycans/G54161DR | denotes | heparin |
| T7 | 437-444 | https://glytoucan.org/Structures/Glycans/G00021MO | denotes | heparin |
| T8 | 437-444 | https://glytoucan.org/Structures/Glycans/G54161DR | denotes | heparin |
| T9 | 474-481 | https://glytoucan.org/Structures/Glycans/G00021MO | denotes | heparin |
| T10 | 474-481 | https://glytoucan.org/Structures/Glycans/G54161DR | denotes | heparin |
| T11 | 556-563 | https://glytoucan.org/Structures/Glycans/G00021MO | denotes | heparin |
| T12 | 556-563 | https://glytoucan.org/Structures/Glycans/G54161DR | denotes | heparin |
| T13 | 594-601 | https://glytoucan.org/Structures/Glycans/G00021MO | denotes | heparin |
| T14 | 594-601 | https://glytoucan.org/Structures/Glycans/G54161DR | denotes | heparin |
| T15 | 640-647 | https://glytoucan.org/Structures/Glycans/G00021MO | denotes | heparin |
| T16 | 640-647 | https://glytoucan.org/Structures/Glycans/G54161DR | denotes | heparin |
| T17 | 727-734 | https://glytoucan.org/Structures/Glycans/G00021MO | denotes | heparin |
| T18 | 727-734 | https://glytoucan.org/Structures/Glycans/G54161DR | denotes | heparin |
| T19 | 829-836 | https://glytoucan.org/Structures/Glycans/G00021MO | denotes | heparin |
| T20 | 829-836 | https://glytoucan.org/Structures/Glycans/G54161DR | denotes | heparin |
| T21 | 1012-1019 | https://glytoucan.org/Structures/Glycans/G00021MO | denotes | heparin |
| T22 | 1012-1019 | https://glytoucan.org/Structures/Glycans/G54161DR | denotes | heparin |
| T23 | 1031-1038 | https://glytoucan.org/Structures/Glycans/G00021MO | denotes | heparin |
| T24 | 1031-1038 | https://glytoucan.org/Structures/Glycans/G54161DR | denotes | heparin |
| T25 | 1230-1237 | https://glytoucan.org/Structures/Glycans/G00021MO | denotes | heparin |
| T26 | 1230-1237 | https://glytoucan.org/Structures/Glycans/G54161DR | denotes | heparin |
Glycosmos6-MAT
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T1 | 1123-1127 | http://purl.obolibrary.org/obo/MAT_0000037 | denotes | vein |
GlycoBiology-FMA
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| _T1 | 23-30 | FMAID:82839 | denotes | heparin |
| _T2 | 23-30 | FMAID:167420 | denotes | heparin |
| _T3 | 104-114 | FMAID:82739 | denotes | amino acid |
| _T4 | 104-114 | FMAID:196728 | denotes | amino acid |
| _T5 | 132-143 | FMAID:63916 | denotes | endothelial |
| _T6 | 132-143 | FMAID:162384 | denotes | endothelial |
| _T7 | 173-180 | FMAID:82839 | denotes | heparin |
| _T8 | 173-180 | FMAID:167420 | denotes | heparin |
| _T9 | 240-251 | FMAID:162384 | denotes | endothelial |
| _T10 | 240-251 | FMAID:63916 | denotes | endothelial |
| _T11 | 240-257 | FMAID:69075 | denotes | endothelial cells |
| _T12 | 240-257 | FMAID:164926 | denotes | endothelial cells |
| _T13 | 240-257 | FMAID:66772 | denotes | endothelial cells |
| _T14 | 240-257 | FMAID:169653 | denotes | endothelial cells |
| _T15 | 252-257 | FMAID:169002 | denotes | cells |
| _T16 | 252-257 | FMAID:68646 | denotes | cells |
| _T17 | 293-300 | FMAID:167420 | denotes | heparin |
| _T18 | 293-300 | FMAID:82839 | denotes | heparin |
| _T19 | 437-444 | FMAID:167420 | denotes | heparin |
| _T20 | 437-444 | FMAID:82839 | denotes | heparin |
| _T21 | 474-481 | FMAID:167420 | denotes | heparin |
| _T22 | 474-481 | FMAID:82839 | denotes | heparin |
| _T23 | 556-563 | FMAID:167420 | denotes | heparin |
| _T24 | 556-563 | FMAID:82839 | denotes | heparin |
| _T25 | 594-601 | FMAID:82839 | denotes | heparin |
| _T26 | 594-601 | FMAID:167420 | denotes | heparin |
| _T27 | 640-647 | FMAID:82839 | denotes | heparin |
| _T28 | 640-647 | FMAID:167420 | denotes | heparin |
| _T29 | 727-734 | FMAID:167420 | denotes | heparin |
| _T30 | 727-734 | FMAID:82839 | denotes | heparin |
| _T31 | 829-836 | FMAID:167420 | denotes | heparin |
| _T32 | 829-836 | FMAID:82839 | denotes | heparin |
| _T33 | 1012-1019 | FMAID:167420 | denotes | heparin |
| _T34 | 1012-1019 | FMAID:82839 | denotes | heparin |
| _T35 | 1031-1038 | FMAID:167420 | denotes | heparin |
| _T36 | 1031-1038 | FMAID:82839 | denotes | heparin |
| _T37 | 1113-1127 | FMAID:171155 | denotes | umbilical vein |
| _T38 | 1113-1127 | FMAID:70317 | denotes | umbilical vein |
| _T39 | 1123-1127 | FMAID:185470 | denotes | vein |
| _T40 | 1123-1127 | FMAID:171667 | denotes | vein |
| _T41 | 1123-1127 | FMAID:50723 | denotes | vein |
| _T42 | 1123-1127 | FMAID:217490 | denotes | vein |
| _T43 | 1123-1127 | FMAID:217063 | denotes | vein |
| _T44 | 1128-1139 | FMAID:63916 | denotes | endothelial |
| _T45 | 1128-1139 | FMAID:162384 | denotes | endothelial |
| _T46 | 1128-1145 | FMAID:66772 | denotes | endothelial cells |
| _T47 | 1128-1145 | FMAID:164926 | denotes | endothelial cells |
| _T48 | 1128-1145 | FMAID:169653 | denotes | endothelial cells |
| _T49 | 1128-1145 | FMAID:69075 | denotes | endothelial cells |
| _T50 | 1140-1145 | FMAID:68646 | denotes | cells |
| _T51 | 1140-1145 | FMAID:169002 | denotes | cells |
| _T52 | 1230-1237 | FMAID:167420 | denotes | heparin |
| _T53 | 1230-1237 | FMAID:82839 | denotes | heparin |
| _T54 | 1294-1299 | FMAID:169002 | denotes | cells |
| _T55 | 1294-1299 | FMAID:68646 | denotes | cells |
uniprot-human
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T1 | 545-547 | http://www.uniprot.org/uniprot/P49366 | denotes | DS |
| T2 | 589-591 | http://www.uniprot.org/uniprot/P49366 | denotes | DS |
| T3 | 635-637 | http://www.uniprot.org/uniprot/P49366 | denotes | DS |
| T4 | 724-726 | http://www.uniprot.org/uniprot/P49366 | denotes | DS |
| T5 | 1028-1030 | http://www.uniprot.org/uniprot/P49366 | denotes | DS |
| T6 | 781-786 | http://www.uniprot.org/uniprot/Q9UC54 | denotes | FGF-2 |
| T7 | 908-913 | http://www.uniprot.org/uniprot/Q9UC54 | denotes | FGF-2 |
| T8 | 791-794 | http://www.uniprot.org/uniprot/Q9BYM0 | denotes | HGF |
| T9 | 918-921 | http://www.uniprot.org/uniprot/Q9BYM0 | denotes | HGF |
uniprot-mouse
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T1 | 781-786 | http://www.uniprot.org/uniprot/P15655 | denotes | FGF-2 |
| T2 | 908-913 | http://www.uniprot.org/uniprot/P15655 | denotes | FGF-2 |
GlycoBiology-NCBITAXON
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T1 | 252-257 | http://purl.bioontology.org/ontology/STY/T025 | denotes | cells |
| T2 | 966-972 | http://purl.bioontology.org/ontology/STY/T096 | denotes | groups |
| T3 | 1140-1145 | http://purl.bioontology.org/ontology/STY/T025 | denotes | cells |
| T4 | 1294-1299 | http://purl.bioontology.org/ontology/STY/T025 | denotes | cells |
| T5 | 1360-1366 | http://purl.bioontology.org/ontology/STY/T096 | denotes | groups |
GO-BP
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T1 | 144-150 | http://purl.obolibrary.org/obo/GO_0040007 | denotes | growth |
| T2 | 189-195 | http://purl.obolibrary.org/obo/GO_0040007 | denotes | growth |
| T3 | 1490-1496 | http://purl.obolibrary.org/obo/GO_0040007 | denotes | growth |
| T4 | 208-226 | http://purl.obolibrary.org/obo/GO_0045840 | denotes | mitogenic activity |
| T5 | 1464-1482 | http://purl.obolibrary.org/obo/GO_0045840 | denotes | mitogenic activity |
| T6 | 551-553 | http://purl.obolibrary.org/obo/GO_0003987 | denotes | Ac |
| T7 | 551-553 | http://purl.obolibrary.org/obo/GO_0043884 | denotes | Ac |
| T8 | 958-965 | http://purl.obolibrary.org/obo/GO_0051923 | denotes | sulfate |
| T9 | 1352-1359 | http://purl.obolibrary.org/obo/GO_0051923 | denotes | sulfate |
| T10 | 979-997 | http://purl.obolibrary.org/obo/GO_0008283 | denotes | cell proliferation |
| T11 | 1474-1496 | http://purl.obolibrary.org/obo/GO_0045927 | denotes | activity of the growth |
GO-MF
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T1 | 173-188 | http://purl.obolibrary.org/obo/GO_0008201 | denotes | heparin-binding |
| T2 | 181-188 | http://purl.obolibrary.org/obo/GO_0070026 | denotes | binding |
| T3 | 181-188 | http://purl.obolibrary.org/obo/GO_0003680 | denotes | binding |
| T4 | 181-188 | http://purl.obolibrary.org/obo/GO_0017091 | denotes | binding |
| T5 | 181-188 | http://purl.obolibrary.org/obo/GO_0005488 | denotes | binding |
| T6 | 181-202 | http://purl.obolibrary.org/obo/GO_0019838 | denotes | binding growth factor |
| T7 | 181-202 | http://purl.obolibrary.org/obo/GO_0048408 | denotes | binding growth factor |
| T8 | 181-202 | http://purl.obolibrary.org/obo/GO_0036458 | denotes | binding growth factor |
| T9 | 181-202 | http://purl.obolibrary.org/obo/GO_0017134 | denotes | binding growth factor |
| T10 | 181-202 | http://purl.obolibrary.org/obo/GO_0048406 | denotes | binding growth factor |
| T11 | 181-202 | http://purl.obolibrary.org/obo/GO_0070851 | denotes | binding growth factor |
| T12 | 1474-1503 | http://purl.obolibrary.org/obo/GO_0008083 | denotes | activity of the growth factor |
GO-CC
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T1 | 252-257 | http://purl.obolibrary.org/obo/GO_0005623 | denotes | cells |
| T2 | 1140-1145 | http://purl.obolibrary.org/obo/GO_0005623 | denotes | cells |
| T3 | 979-983 | http://purl.obolibrary.org/obo/GO_0005623 | denotes | cell |
UBERON-AE
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T1 | 1113-1127 | http://purl.obolibrary.org/obo/UBERON_0002066 | denotes | umbilical vein |
| T2 | 1113-1139 | http://purl.obolibrary.org/obo/UBERON_0007777 | denotes | umbilical vein endothelial |
| T3 | 1123-1127 | http://purl.obolibrary.org/obo/UBERON_0001638 | denotes | vein |
GlycoBiology-MAT
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T1 | 1123-1127 | http://purl.obolibrary.org/obo/MAT_0000037 | denotes | vein |
GlycoBiology-Motifs
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T1 | 23-30 | http://rdf.glycoinfo.org/glycan/G54161DR | denotes | heparin |
| T2 | 173-180 | http://rdf.glycoinfo.org/glycan/G54161DR | denotes | heparin |
| T3 | 293-300 | http://rdf.glycoinfo.org/glycan/G54161DR | denotes | heparin |
| T4 | 437-444 | http://rdf.glycoinfo.org/glycan/G54161DR | denotes | heparin |
| T5 | 474-481 | http://rdf.glycoinfo.org/glycan/G54161DR | denotes | heparin |
| T6 | 556-563 | http://rdf.glycoinfo.org/glycan/G54161DR | denotes | heparin |
| T7 | 594-601 | http://rdf.glycoinfo.org/glycan/G54161DR | denotes | heparin |
| T8 | 640-647 | http://rdf.glycoinfo.org/glycan/G54161DR | denotes | heparin |
| T9 | 727-734 | http://rdf.glycoinfo.org/glycan/G54161DR | denotes | heparin |
| T10 | 829-836 | http://rdf.glycoinfo.org/glycan/G54161DR | denotes | heparin |
| T11 | 1012-1019 | http://rdf.glycoinfo.org/glycan/G54161DR | denotes | heparin |
| T12 | 1031-1038 | http://rdf.glycoinfo.org/glycan/G54161DR | denotes | heparin |
| T13 | 1230-1237 | http://rdf.glycoinfo.org/glycan/G54161DR | denotes | heparin |
performance-test
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| PD-UBERON-AE-B_T1 | 1113-1127 | http://purl.obolibrary.org/obo/UBERON_0002066 | denotes | umbilical vein |
| PD-UBERON-AE-B_T2 | 1113-1139 | http://purl.obolibrary.org/obo/UBERON_0007777 | denotes | umbilical vein endothelial |
| PD-UBERON-AE-B_T3 | 1123-1127 | http://purl.obolibrary.org/obo/UBERON_0001638 | denotes | vein |
Anatomy-MAT
| Id | Subject | Object | Predicate | Lexical cue | mat_id |
|---|---|---|---|---|---|
| T1 | 1123-1127 | Body_part | denotes | vein | http://purl.obolibrary.org/obo/MAT_0000037 |
mondo_disease
| Id | Subject | Object | Predicate | Lexical cue | mondo_id |
|---|---|---|---|---|---|
| T1 | 545-550 | Disease | denotes | DS, N | http://purl.obolibrary.org/obo/MONDO_0007790 |
NCBITAXON
| Id | Subject | Object | Predicate | Lexical cue | db_id |
|---|---|---|---|---|---|
| T1 | 1107-1112 | OrganismTaxon | denotes | human | 9606 |
Anatomy-UBERON
| Id | Subject | Object | Predicate | Lexical cue | uberon_id |
|---|---|---|---|---|---|
| T1 | 231-257 | Body_part | denotes | vascular endothelial cells | http://purl.obolibrary.org/obo/CL_0002139 |
| T2 | 1113-1127 | Body_part | denotes | umbilical vein | http://purl.obolibrary.org/obo/UBERON_0002066 |
| T3 | 1128-1145 | Body_part | denotes | endothelial cells | http://purl.obolibrary.org/obo/CL_0000115 |